1. Introduction {#sec1}
===============

In Africa we have experienced a landslide of antimicrobial resistance (AMR) among gram-negative bacteria (GNB) and the clinical consequences of this misfortune, while three groups of gram-negative bacteria have been named critical antimicrobial resistance-related threats globally by WHO \[[@bib1], [@bib2], [@bib3], [@bib4]\]. The related AMR situation is still astonishingly muted and manageable in affluent countries \[[@bib5], [@bib6]\]. Improved insight into global health-related aspects is now necessary to understand the circumstances that made not less than three different groups of GNB the uppermost AMR-related threats worldwide [@bib4].

Antimicrobial resistance is accumulated when bacteria are exposed to antibiotics. However, while variations are noted, the association between consumption of antimicrobials and antimicrobial resistance is generally weak [@bib7]. Antimicrobial resistance also depends on factors that have so far not been accounted for \[[@bib8], [@bib9]\]. To understand their importance, we obviously need to make them countable, but we lack the needed measure.

Through our work in Europe and Africa, we have noticed that environmental bacteria, in particular Acinetobacter spp., are common pathogens in nosocomial sepsis cohorts that also have exceptionally high rates of resistant Enterobacteriaceae [@bib2]. This impression was strengthened through unstructured review of reports from others \[[@bib10], [@bib11], [@bib12]\]. Any association between disease burden of Acinetobacter spp. and rates of resistance among Enterobacteriaceae would be of major epidemiological importance:-It would mean that the critical epidemics of AMR related to Enterobacteriaceae and environmental bacteria are not independent epidemics; they would either be mutually supportive, or have a promoting factor in common.-Association between AMR among enteric bacteria and a variable that belongs to the environment (Acinetobacter spp.) would link magnitude of AMR to one measurable element within the environment. This would make Acinetobacter spp. a surrogate marker and a candidate measure for impact of the therapeutic environment on accumulation of AMR.

We have therefore studied the association between burden of Acinetobacter spp. as nosocomial pathogens and antimicrobial resistance among Enterobacteriaceae in clinical reports from Europe and Africa. To assess the quality of evidence in case of a positive correlation, we also analysed the association based on entirely different data, i.e. from national European records that were published by the European Centre for Disease Prevention and Control (ECDC).

The first part thus concerned clinical studies from Europe and Africa. During the preparatory phase, we became aware of a number of challenges. While recommendations for increased stringency in research were observed \[[@bib13], [@bib14], [@bib15]\], clinical discrepancies of major epidemiological importance were commonly not accounted for. Levels of antimicrobial resistance differ greatly, not only between cohorts with community-acquired (CAI) and hospital acquired infections (HAI), but also between invasive and non-invasive infections \[[@bib3], [@bib6]\]. Correct handling of bacteriological and susceptibility-related results would thus be separate specimen-dependent tables for HAI and CAI cohorts. Because sufficiently detailed tables were commonly not offered, we adopted a review procedure that included in depth review of text and tables. Following this, a number of studies were found to have result entries that were either incorrect (mixture of patients\' cohorts), or missing. To our knowledge, standard procedures that are sufficiently detailed about management of such cases do not exist \[[@bib13], [@bib14], [@bib15]\]. This was thus handled as described below.

African reports were indispensable in the present study, but previous review studies have all failed to include reports from Africa on invasive nosocomial infections [@bib16]. There are reviews on blood stream infections that include African studies, but they do not contain cases of hospital-acquired infection [@bib17]. Then there are reviews on hospital-acquired infections that include African studies, but they do not contain African cases of invasive infections \[[@bib18], [@bib19]\]. Through thorough examination as described above, we identified relevant African studies that fulfilled the eligibility criteria.

For the study of national reports, sources of aggregated data were sought for. While the European Centre for Disease Prevention and Control (ECDC) has published reports about AMR rates for relevant pathogens in most European states for a number of years, proportion of Acinetobacter spp. as nosocomial pathogens could only be found in one point prevalence study (PPS) presenting data from 2012 \[[@bib5],[@bib20],[@bib21]\]. The second ECDC PPS was organized in 2016--2017, but data published so far do not contain prevalence of nosocomial pathogens.

Relating antimicrobial resistance among Enterobacteriaceae to the prevalence of a different group of bacteria has not been done before. There are thus no previous reports for comparison. Instead, related methodological, biological and epidemiological aspects were discussed.

2. Methods {#sec2}
==========

Throughout the study, reported resistance were rates of antimicrobial resistance towards third generation cephalosporins (3GC). The highest number reported for resistance to any one of ceftazidime, ceftriaxone, cefotaxime, or report of ESBL, was recorded.

2.1. Review of HAI studies/reports from European and African institutions {#sec2.1}
-------------------------------------------------------------------------

PRISMA flow diagram was followed [@bib22]. The applied database was Ovid MEDLINE, and the search was performed by qualified librarians. The search strategy itself included clinical (sepsis, septic?emi\*, bacter?emi\*, bloodstream, blood stream infection), cohort-related (hospital-acquired, HAI, nosocomial infection), geographical \[continent Africa plus all African countries by name; continent Europe plus three South-European (Greece, Italy, Spain) and four North- European countries (Norway, Sweden, Finland, Denmark) by name\], as well as time-related aspects (2010-current). The mentioned countries were selected to ensure inclusion of studies from areas with high, middle and low prevalence of antimicrobial resistance.

Review of all abstracts and full texts as well as the following decisions were made by two or more authors. HAI studies with reports on blood culture isolates, or general sepsis studies that also contained these informations as a subgroup were selected. These were reviewed in full text to identify those from which the following information could be provided either directly, or derived indirectly:•number of Acinetobacter spp. isolates,•Total number of GNB isolates, and•rate of 3GC resistant Enterobacteriaceae isolates.

Minimum accepted study size was defined by GNB = 30 cases. Multicenter studies were included, even those involving centers outside Europe and Africa provided that institutions from either of these two continents were also included.

Articles that met these criteria were subjected to final quality check of data. This was done to confirm the following:•cases belonged to target cohort (HAI/HCAI cases),•correct specimen for all cases (blood cultures),•number of missing or doubtful entries for all target parameters.

Reports were accepted when missing or doubtful entries for any parameter concerned were ≤15%. Doubtful entries would be doubtful or possible CAI cases, and those where kind of specimen could not be ascertained. Care was made to ensure correct number for Acinetobacter spp. Studies reporting of non-fermenting bacteria without further identification were thus only accepted when this group of bacteria was ≤15% of those already identified as Acinetobacter spp. There was one exception, however, where the rate of non-Pseudomonas non-fermenters was exceptionally low, i.e. 2% [@bib33]. In that case, proportion of Acinetobacter spp. was given the value 1%. This study was included as explained further down.

Authors were asked for additional information when missing or doubtful entries concerned \>15 % - 50% of entries for any given variable. Inclusion would then depend on the author\'s answer. Reports were excluded when missing or doubtful entries concerned the majority of entries for any variable.

While community acquired infections (CAI) were thus weeded out, cases defined by the author as health care associated infection (HCAI) were counted as HAI cases. Lack of susceptibility test results for Enterobacter spp., was expected and accepted \[[@bib23], [@bib24]\].

The fraction of Acinetobacter spp. by total number of GNB isolates was named Proportion of Acinetobacter spp. Correlation between Proportion of Acinetobacter spp. and rate of 3GC resistant Enterobacteriaceae was then calculated, both as simple correlation of proportions and on log scale.

2.2. National reports {#sec2.2}
---------------------

This part was based on data from European Antimicrobial Resistance Surveillance (EARS)/European Centre for Disease Prevention and Control (ECDC) \[[@bib5], [@bib20], [@bib21]\]. We recorded rates of Acinetobacter spp. as they were given in "Point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011--2012" (isolates of Acinetobacter spp. by total number of HAI isolates), and rates of resistant *K. pneumonia* in national blood culture records from countries that reported to EARS in 2012 \[[@bib36],[@bib38]\].

Correlation coefficient (Pearson\'s *r*) and *r*^*2*^ for the association between prevalence of Acinetobacter spp. and rate of 3GC resistant *K. pneumonia* were then calculated.

3. Results {#sec3}
==========

3.1. Review of HAI studies {#sec3.1}
--------------------------

Outcome of the search and selection process is given in [Fig. 1](#fig1){ref-type="fig"}. The database search yielded 522 articles, to which 15 more were obtained via citation chasing. Following the abstract review, 124 selected reports were assessed in full text for eligibility. Of these, 103 were excluded because they did not meet the eligibility criteria. In four of the studies, all needed variables were easily retrieved from the tables, and these studies were included immediately. Crucial characteristics, comments and result are given in [Table 1](#tbl1){ref-type="table"} for these four and the remaining 17 studies that were subjected to the final quality check \[[@bib3], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44]. Six of these 17 studies were included following cross-check of text and tables. One study was excluded because cohort affiliation (HAI or CAI) for majority of susceptibility test results could not be accounted for [@bib3]; two because susceptibility results for Enterobacteriaceae were not given \[[@bib30], [@bib31]\]; one study because susceptibility test had not been performed for the majority of isolates [@bib39]; one because it was a sub-study, and the main study was already included [@bib32]. In the remaining six cases, authors were asked to provide for additional information about exact number of resistant isolates of a given species \[[@bib28], [@bib33], [@bib36], [@bib37]\], or number of *Acinetobacter* isolates \[[@bib29], [@bib43]\]. Three of the authors gave the needed information which lead to the inclusion of their studies. Two refrained from answering while one author told that he was unable to give the needed data. There were thus 13 studies for calculation of the correlation coefficient ([Table 2](#tbl2){ref-type="table"} and [Fig. 2](#fig2){ref-type="fig"}).Fig. 1Selection process.Fig. 1Table 1Crucial data and outcome of quality check.Table 1RefFirst AuthorCountryInstitutionPatients\' cohortsSampling yearPending issue, and outcome of quality check.Metho-dologyGNB (no)Entero-bacteriaceae (no)Resistance rate Entero-bateriaceaeProportion of Acinetobacter (%)Quality[@bib3]MainaKenyaAga Khan Gen.Hospital NairobiNICU, Paediatric, Medical, Surgical2010-14Susceptibility test results given for HAI and CAI combined, 70% being CAI. **Not inclued**CLSI189152NG11-[@bib25]MorkelSouth AfricaTygerberg Childrens Hospital Cape TownChildren including neonates200815% of specimen harvested \< 48 h after admission or birth. **Included**CLSI38235337+[@bib26]DramowskiSouth AfricaTygerberg Childrens Hospital Cape TownNeonates2009-13Susceptibility of Enterobacteriaceae concerns *Klebsiellae pneumoniae* and *E. coli* only (=88,5% of all Enterobacteriaceae) **Included**CLSI5194264913+[@bib27]McKaySouth AfricaGroote Schuur Hospital, Cape TownAdult patients2011-12**Included**CLSI3662144024+[@bib28]ZorganiLibyaBurn and Plastic Surgery CentreBurn cases2000 - 2007Missing susceptibility test results. (Author's answer). **Not inclued**NG17057NG6-[@bib29]SaiedEgyptMulticentre3 univ hosp2006-7No. of *Acinetobacter spp*. uncertain: 29 isolates identified, in addition 33 \"Nonfermenter spp\", i.e. proportion of Acinetobacter 7,5 - 16,1. **Not inclued**CLSI38626766NG-[@bib30]SeeEgyptMulticentre46 egyptian ICUs, all ages(incl 8 NICUs)2011-12Only 88/362 isolates (24%) sent for susceptibility test. **Not inclued**CLSI5129NG13-[@bib31]TalaatEgyptIncl. 91 ICUs, 28 Hospitals in Egypt.NICU, Paediatric, Medical, Surgical, Neurological2012-14Microbes and susceptibility results given for all types of samples/specimen in one. **Not inclued**CLSINGNGNGNG-[@bib42]LachhabMoroccoMohammed V Military Teaching HospitalICU2012 - 13**Included**NG45255729+[@bib38]MittEstoniaPICU, Tartu University HospitalPICU2004-8**Included**CLSI47392311+[@bib43]HorcajadaSpain8 Spanish ICUsUnselected sepsis patients2010-11Author's clarification about number of Acintobacter isolates. **Included**CLSI371339131+[@bib33]BartolettiItalyOrsola-Malpighi Hospital Bologna, Italy8874 patients with cirrhosis2008-12Missing test results provided by author. **Included**CLSI / EUCAST104773910+[@bib44]SofticBosnia-HerzegovinaUniversity Clinical Centre TuzlaNICU2012 - 13\
**Included**CLSI32195819+[@bib40]ReunesBelgiumGhent University HospitalGeriatric patients1992-2007**Included**NCCLS766153+[@bib34]De BusBelgiumGhent University HospitalUnselected HAI cohort2009 - 11Susceptibility results given as mean for all GNB, but 86% of GNB are Enterobacteriaceae. **Included**NG565487171+[@bib41]TabahEurope162 intensive care units (ICUs) in 24 countries.Unselected HAI cohorts2009**Included**NG7593425621+[@bib39]Perez LopezUKSt. George's Hospital NHS Trust,Pediatric/NICU2001-9Only 33% of all Enterobacteriaceae tested for suceptibility. **Not inclued**BSAC10878NG6-[@bib37]MelzerUKRoyal London Hospital, Barts Health NHS Trust,UTI associated bacteremia2007-8Report of 6 ESBL positives in subset of 83 isolates - number of tested isolates not given. **Not inclued**BSAC7162NG0-[@bib32]ÅttmanFinlandTampere University HospitalHaematho-logical malignancies1999-2001 and 2005-07Study population is part of other included study. **Not inclued**CLSI / EUCAST17111560-[@bib35]HuttunenFinlandTampere University HospitalUnselected HAI cohort1999-2001 and 2005-07Acinetobacter-rate not given, but no. of non-Pseudomonas non-Enterobacteriaceae GNB was 11, i.e. 2,0% of GNB. Proportion of Acinetobacter defined by us as 1%. **Included**CLSI / EUCAST54845031+[@bib36]MehlNorwayNord-Trøndelag Hospital TrustUnselected sepsis cases2002 - 13Missing susceptibility results supplied on demand. **Included**EUCAST58648341+[^1]Table 2Correlation between proportion of Acinetobacter spp. and rates of antimicrobial resistance among Enterobateriaceae, from simple correlation to more statistically sound calculations on log scale accounting for observation uncertainty due to limited number of samples. (Based on reports from European and African institutions).Table 2MeasurementCorrelation with 95% confidence interval[∗](#tbl2fnlowast){ref-type="table-fn"}a) Basic correlation of proportions0.85 \[0. 74, 0.95\]b) Correlation of proportions on log scale0.88 \[0.78, 0.97\]c) Correlation of proportions on log scale; accounting for observation uncertainty[∗∗](#tbl2fnlowastlowast){ref-type="table-fn"}**0.96 \[0.80, 0.99\]**[^2][^3]Fig. 2Correlation between Proportion of Acinetobacter spp. (see text), and resistance towards third generation Cephalosporins among Enterobacteriaceae; Left (a) absolute proportions, right (b) proportions on log scale with fitted regression line. (Based on reports from European and African institutions).Fig. 2

The correlation coefficient was high with all applied methods. On log-log scale, the correlation coefficient was 0.88. In one included study, the proportion of Acinetobacter spp. was \<2%, and given the value 1% by us ([Fig. 2](#fig2){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}) [@bib35]. The correlation coefficient would have been 0.85 and 0.89, respectively, if the given value for proportion of Acinetobacter spp. in the concerned study had been 2% or 0.1% instead [@bib35]. When calculated by proportions on log scale accounting for observation uncertainty due to limited number of samples, Pearson\'s *r* was 0.96 (0.80, 0.99).

3.2. National reports {#sec3.2}
---------------------

The correlation coefficient (*r*) between rates of resistance among *K. pneumoniae* and proportion of Acinetobacter spp. was 0.80 (0.56, 0.92) \[*r*^*2*^ = 0.64 (0.31, 0.84)\]

4. Discussion {#sec4}
=============

The correlation between prevalence of Acinetobacter spp. and rates of antimicrobial resistance among Enterobacteriaceae was very high and had a narrow confidence interval that reached 0.99. Ninety-two per cent of the observed resistance among Enterobacteriaceae could thus be explained by the corresponding burden of Acinetobacter spp. (*r*^*2*^) based on the review of clinical studies. The evidence quality consisted of the strength of this correlation, plus the fact that equal results were reached through two entirely different approaches: clinical studies and national reports [@bib45].

The understanding is that the simultaneous epidemics of AMR among Enterobacteriaceae and non-fermenting bacteria are related. Either, these epidemics have a common promoting factor, or they are mutually supportive.

Further, this is the first report of a link between resistance patterns among enteric bacteria and the disease burden of bacteria that originate from the therapeutic environment itself. Different aspects of hospital operation that affect burden of Acinetobacter spp., are of equal importance for promotion or prevention of AMR build-up.

4.1. Antimicrobial resistance among enteric bacteria covariates with level of nosocomial pathogens originating from the environment. Which are the implications? {#sec4.1}
----------------------------------------------------------------------------------------------------------------------------------------------------------------

The association between a family of nosocomial pathogens (Acinetobacter spp.) and levels of antimicrobial resistance among Enterobacteriaceae highlights the complexity of AMR accumulation. The risk for hospital-acquired infections increases when advanced medical and surgical procedures are introduced, and so does the levels of antimicrobial resistance \[[@bib18], [@bib46]\]. It was unfortunate, but probably not an accident, that increased rates of antimicrobial resistant GNB coincided with the introduction of advanced medical and surgical procedures in Africa, and Low and Middle Income Countries (LMIC) elsewhere [@bib47]. Not counted as prestigious activities, bacteriological services and hospital hygiene have low priority, while cardiovascular and other advanced surgical services are now being introduced \[[@bib48], [@bib49]\]. Symbol equipment like ventilators are introduced as hardly affordable and very unfortunate substitutes for safe and comprehensive intensive care [@bib50]. As highlighted here, hospital management without bacteriological services is no longer an option. It is always unfortunate when the level of advanced and device-dependent medical care is not balanced against the institutions' ability to record and manage problems that follow advanced medical care [@bib51]. In health care settings where non-fermenters and other contaminants are constantly sought for and immediately removed whenever found, any co-existence between Enterobacteriaceae and non-fermenting bacteria would be occasional and of short duration. In the absence of bacteriological services and strong hospital hygiene, however, contaminants may unnoticed live as endemic parts of the environment [@bib19].

4.2. Amplified build-up of antimicrobial resistance: synergy between non-related gram-negative bacterial species after all? {#sec4.2}
---------------------------------------------------------------------------------------------------------------------------

The simultaneous epidemiological success of three different groups of gram-negative bacteria has now forced us to study the significance of differently composed multi-bacterial environments for production of AMR \[[@bib7], [@bib52], [@bib53]\]. Enhanced acquirement and propagation of AMR by non-fermenting bacteria, and reception of these elements by Enterobacteriaceae, have all been described \[[@bib52], [@bib54], [@bib55]\]. Theoretically, AMR production could thus be amplified when mutually complementary bacterial properties are brought together.

Horizontal gene transfer (HGT) of ESBL between Enterobacteriaceae and Acinetobacter spp. has not been regarded as a matter of importance. Class A beta-lactamases, common to Enterobacteriaceae, are seldom found among Acinetobacter spp \[[@bib56], [@bib57], [@bib58]\]. While Acinetobacter spp. thus do not keep Class A beta-lactamases themselves, to some extent they do acquire and propagate plasmids that contain the concerned sequences \[[@bib52], [@bib59], [@bib60], [@bib61]\]. The significance of this contribution to build-up of AMR within a multi-bacterial environment has not been studied, but this can be done. It is now possible to follow transfer of AMR from donor to receiving bacteria \[[@bib62], [@bib63]\].

Shared plasmids and shared clonal resistance among different species has not been extensively studied \[[@bib62], [@bib64], [@bib65]\]. It could nevertheless be widespread, both across species borders and geographical borders. In 2003, 13 different blood culture isolates, representing 4 different species (all Enterobacteriaceae) were harvested among Tanzanian children \[[@bib66], [@bib67]\]. The 13 isolates had one common plasmid, which carried resistance towards 5 antibiotics (3GC, gentamicin, chloramphenicol, co-trimoxazole and tetracycline). When looked after ten years later, we found that the majority of 92 pediatric GNB blood culture isolates in Addis Ababa, Ethiopia, expressed equal AMR phenotypes. This resistance pattern was found regardless of species, 32% of isolates being non-fermenting bacteria [@bib2].

At present, the most important AMR-related task is thus to understand how three groups of gram-negative bacteria became our three critical AMR-related problems. We have shown that two of them are linked together, and thus not independent epidemics. While antimicrobial consumption remains the trigger of AMR accumulation, the extent of AMR accumulation depends on the antimicrobial resistance vulnerability of the nosocomial environment. We have offered a candidate measure for such vulnerability.

4.3. Needed research {#sec4.3}
--------------------

Research related to AMR needs reorientation: thematically to focus on the different elements that amplify AMR production, geographically to reach study populations where AMR build-up is fast, and bacteriologically to secure that WHO\'s three critical issues are granted top priority.

More detailed, further research is needed to identify the forces behind the rapid and simultaneous epidemiological success of three groups of gram-negative bacteria. As part of this, we need to know if co-existence between Acinetobacter spp. and Enterobacteriaceae affects rates of AMR. Then the following questions need to be answered: Is burden of Acinetobacter spp. a useful measure for the environment\'s impact on AMR build-up in hospitals? Are antimicrobial stewardship programs at all helpful when rates of AMR and burden of Acinetobacter spp. are both high - or should improved hospital hygiene be addressed to reduce the burden of Acinetobacter spp. first? Is co-existence of gram-negative bacterial species with mutually complementary properties for acquisition and propagation of plasmids optimal for spread of AMR?

It has previously been stated that "large-scale dissemination of multi-resistant pathogens in the hospital environment, the community, and the wider environment is one of the most important emerging public health threats" [@bib54]. The distinction between these three levels is probably as important as their relatedness. We need to understand the process that transforms health care facilities into sources of AMR, where after AMR is spread into the catchment areas and beyond by Enterobacteriaceae. Having reached out into the community, AMR rates are further increased through unstructured and high use of antibiotics \[[@bib68], [@bib69], [@bib70], [@bib71]\]. When thresholds for hospital admission are as high as they are unpredictable, room is created for unstructured and unpredictable pre-hospital management and AMR build-up [@bib72]. While working on this project, the main challenge was poor availability of reliable data. In particular, we missed tables of antimicrobial susceptibility results with respect to species, kind of specimen, clinical data, and matching cohort. If appropriate datasets had followed reports as attachments, this problem would have been solved.

4.4. Limitations {#sec4.4}
----------------

### 4.4.1. Clinical studies {#sec4.4.1}

Because of the highly detailed review process, we became aware of studies with missing or incorrect data entries for one or more of the variables. We decided to accept studies when missing or incorrect entries were random and to low to be of importance - defined as 15% of all entries for a given variable. We were not aware of any standard procedure for how to handle this, and the method we developed and used had thus not been validated or applied before.

To manage the detailed review as described above in a proper way, a database search procedure was used that would leave out maximum of irrelevant or low quality reports. It is possible that a broader search could have given an even higher number of included studies.

### 4.4.2. National reports {#sec4.4.2}

The ECDC report did not contain breakdowns for causative agents in blood cultures. We therefore applied the reported proportion for *Acinetobacter* spp. for all specimens, while rates of AMR concerned blood culture results only. A more reliable and probably an even stronger correlation would have been the result if proportion for *Acinetobacter* spp. had solely been based on blood culture reports in HAI.

Quality of bacteriological methods including species identification, susceptibility tests and ESBL identification was not assessed.
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[^1]: Ref: Reference; no: number; NICU: Newborn Intensive Care Unit; HAI: Hospital acquired infection; CAI: Community acquired infection; CLSI: Clinical & Laboratory Standards Institute; EUCAST: European Committee on Antimicrobial Susceptibility Testing; BSAC: British Society for Antimicrobial Chemotherapy; NCCLS: National Committee for Clinical Laboratory Standards; NG: not given; ICU: Intensive Care Unit; PICU: Pediatric Intensive Care Unit; GNB: Gram-negative bacteria; UTI: Urinary tract infection.

[^2]: Confidence intervals for (a) and (b) calculated by bootstrap replications.

[^3]: Calculated using Bayesian Gibbssampler assuming multivariate normal distributions and flat priors.
